Showing results (1521-1530 of 1,745) with videos related to

Sort By:
Pageof 175
Virulence|July 30, 2020
Development of a fully automated high throughput PCR for the detection of SARS-CoV-2: The need for speedFlorian J Mayer, Franz Ratzinger, Ralf L J Schmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803Monica M Bertagnolli, Robert S Warren, Donna Niedzwiecki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2017
Development and Validation of the PREMM<sub>5</sub> Model for Comprehensive Risk Assessment of Lynch SyndromeFay Kastrinos, Hajime Uno, Chinedu Ukaegbu, et al.
Diabetes Care|November 22, 2014
The SEARCH for Diabetes in Youth study: rationale, findings, and future directionsRichard F Hamman, Ronny A Bell, Dana Dabelea, et al.
Diabetes Care|July 29, 2006
Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth studyBeatriz L Rodriguez, Wilfred Y Fujimoto, Elizabeth J Mayer-Davis, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|June 8, 2011
[Treatment of patients with relapsed/refractory Hodgkin lymphoma]H Mociková, R Pytlík, L Raida, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|November 11, 2011
[Partial regression of CNS lesions of Erdheim-Chester disease after treatment with 2-chlorodeoxadenosine and their full remission following treatment with lenalidomide]Z Adam, A Sprláková, Z Rehák, et al.
Diabetes Care|September 18, 2013
Prevalence of diabetes in U.S. youth in 2009: the SEARCH for diabetes in youth studyDavid J Pettitt, Jennifer Talton, Dana Dabelea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2006
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidinesHeinz-Josef Lenz, Eric Van Cutsem, Shirin Khambata-Ford, et al.
Pageof 175